An insurance benefit that provides percutaneous coronary intervention patients with a discharge supply of antiplatelet medication could result in cost savings for insurers.
Nathan W. Carroll, MHA
Advertisement
Articles by Nathan W. Carroll, MHA
Advertisement
Latest Updated Articles
- Costs of Providing Antiplatelet Medication for Percutaneous Coronary Intervention Patients
Published: December 21st 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Energy Insecurity Linked to Higher Depression, Anxiety in US Adults
2
FDA Expands Sotatercept Indication for PAH
3
Patients, Providers Strongly Favor Oral Therapies in Psoriasis
4
Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear
5
